• 제목/요약/키워드: 단삼 추출액

검색결과 12건 처리시간 0.016초

전통식품 및 천연물에서 천연보존료 개발에 관한 연구 (Studies on the Development of Natural Preservatives from Natural Products)

  • 김희연;이영자;홍기형;권용관;이주연;김소희;하상철;조홍연;장이섭;이철원;김길생
    • 한국식품과학회지
    • /
    • 제31권6호
    • /
    • pp.1667-1678
    • /
    • 1999
  • 식품원재료 171종과 한약재 190종의 metanol 추출물의 항균활성을 조사하였다. 항균활성은 식품의 부패, 변질에 관여한다고 알려진 그람양성세균인 Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Listeria monocytogenes, 그람음성세균인 Pseudomonas aeruginosa, Salmonella typhimurium, Escherichia coli 및 효모인 Saccharomyces cerevisiae, Candida albicans, 곰팡이 Penicillium citrinum, Aspergillus flavus, Aspergillus niger를 대상으로 측정하였다. 산수유, 오수유, 감초, 단삼, 오미자, 황련, 명일엽, aroma hop와 bitter hop는 그람양성세균에 항균활성을 나타내었다. Aroma hop와 bitter hop는 그람음성세균에 항균활성을 나타내었다. 한편, 그람양성세균에 대해 강한 항균활성을 나타낸 단삼으로부터 항균물질을 분리, 정제하고 그 구조를 결정하였다. 단삼의 methanol 추출액을 농축하여 ethylacetate로 extraction, silicagel column chromatography, preparative TLC, preparative HPLC 등을 통하여 보존활성물질(T-1)을 분리, 정제하고 UV, $^1H-NMR,\;^{13}C-NMR$, DEPT 및 EI-MS 등의 기기분석한 결과, 단삼의 항균활성물질은 cryptotanshinone으로 결정되었다. 그람양성균에 대하여 MIC는 $3.91{\sim}62.50\;{\mu}g/mL$ 범위에서 강한 보존활성을 나타내었고 특히 Bacillus subtilis에 대하여 MIC는 $3.91\;{\mu}g/mL$로 가장 강한 보존활성을 나타내었다. 따라서 단삼의 cryptotanshinone은 그람양성세균 및 그람음성세균에 의해 변패될 수 있는 식품에서 천연보존료로 이용 가능할 것으로 생각된다.

  • PDF

항장요법(肛腸療法)에 의한 단삼추출액(丹蔘抽出液)의 알레르기반응 억제효과(抑制效果) (Inhibitory Effects of Allergic Reaction of Aqueous Extract of Salviae Radix Root by Anal Therapy)

  • 조정연;문석재;문구;원진희;김형민
    • 대한한의학회지
    • /
    • 제20권1호
    • /
    • pp.11-21
    • /
    • 1999
  • Dansam, the root of Salvia miltiorrhiza BGE. (Labiatae), has a bitter and a slightly 'cold' property. and is nontoxic. It has been used for the treatment of diseases such as tumors, bruises, gynecologic diseases, menoxenia, anemia and so forth. As an oriental medicine pathway, anal therapy has many kinds of treatments, Retention enema is one the most useful, advantageous methods of anal therapy. This experiment was performed in order to study the effect of an aqueous extract of Salviae radix root(SRRAE) on Immediate type allergic reaction by Retention enema. The results were obtained as follows, 1. SRRAE inhibited compound 48/80-induced Immediate type allergic reaction 100% with the dose of 0.1g/kg by anal treatment. However, SRRAE showed no significant inhibitory effect on the same reaction by oral treatment. When mice were pretreated with SRRAE at a concentration ranging from 0.001 to 1.0g/kg, by intra-anal treatment, the serum histamine levels were reduced in a dose-dependent manner. 2. SRRAE also inhibited by 79.8% local cutaneous allergic reaction activated by anti-dinitrophenyl (DNP) IgE. 3. SRRAE close-dependently inhibited the histamine release from rat peritoneal mast cells(RPMC) by anti-DNP IgE., but SRRAE not inhibited compound 48/80-induced histamine release. 4. SRRAE dose-dependently inhibited tumor necrosis $factor-\;{\alpha}$ $(TNF-\;{\alpha}$) production from RPMC by anti-DNP IgE. Moreover, the level of cAMP in RPMC, when SRRAE was added, significantly increased compared with that of a normal control. According to the above results, anal therapy(Retention enema) of SRRAE may be beneficial in the treatment of systemic and local Immediate type allergic reactions.

  • PDF